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Effect of nitric oxide donors on renal tubular epithelial cell- shown that urinary casts, which consist of Tamm-Horsfall
matrix adhesion. mucoprotein, brush border membranes, and conglomer-
Background. Nitric oxide (NO) and its metabolite, peroxy- ated tubular epithelial cells, contribute to the obstructionnitrite (ONOO2), are involved in renal tubular cell injury. We
[10]. Racusen, Fivush, and Li demonstrated, by trypanpostulated that if NO/ONOO2 has an effect to reduce cell
blue dye exclusion and subsequent in vitro culture, thatadhesion to the basement membrane, this may contribute to
tubular obstruction and may be partially responsible for the more than 30% of renal tubular cells recovered in urine
harmful effect of NO on the tubular epithelium during acute from patients with acute tubular necrosis were viable
renal failure (ARF). [11]. Graber et al also reported viable tubular cells inMethods. We examined the effect of the NO donors (z)-1-
the urine sediment in patients with acute renal failure[2-(2-aminoethyl)-N-(2-ammonioethyl)amino]diazen-1-ium-1,
(ARF) and other renal disorders [12]. Moreover, these2-diolate (DETA/NO), spermine NONOate (SpNO), and the
ONOO2 donor 3-morpholinosydnonimine (SIN-1) on cell- exfoliated tubular cells have changes in their cytoskele-
matrix adhesion to collagen types I and IV and fibronectin ton and cell–cell and cell–matrix adhesion that may be
using three renal tubular epithelial cell lines: LLC-PK1, BSC-1, responsible for their anatomical and functional abnor-and OK.
malities [13–15]. This cytoskeletal disruption and subse-Results. In LLC-PK1 cells, DETA/NO (500 mm) had no effect,
quent cell adhesion disassembly may lead to apoptosisand SpNO (500 mm) had a modest effect on cell adhesion com-
pared with controls. Exposure to SIN-1 caused a dose-dependent in anchorage-dependent cells [16–19].
impairment in cell-matrix adhesion. Similar results were ob- Previous studies from our laboratory and others have
tained in the different cell types and matrix proteins. The effect demonstrated that cytosolic calcium [20–24] and nitricof SIN-1 (500 mm) on LLC-PK1 cell adhesion was not associated
oxide (NO) may play an important role in renal tubularwith either cell death or alteration of matrix protein and was
attenuated by either the NO scavenger 2-(4-carboxyphenyl)- cell injury in vitro [25, 26] and in vivo ischemic ARF
4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide, the superoxide [27, 28]. Although NO has been demonstrated to be
scavenger superoxide dismutase, or the ONOO2scavenger uric beneficial in the vasculature by attenuating leukocyte-
acid in a dose-dependent manner.
endothelial cell adhesion during postischemic reperfu-Conclusions. These results therefore support the possibility
sion injury [29–32], it may play a damaging role in renalthat ONOO2 generated in the tubular epithelium during ische-
mia/reperfusion has the potential to impair the adhesion prop- tubular epithelium by attenuating tubular cell adhesion
erties of tubular cells, which then may contribute to the tubular and contributing to tubular obstruction. A similar effect
obstruction in ARF. has been shown in mesangial cell-matrix adhesion [33].
The NO donor S-nitroso-N-acetyl-D,L-penicillamine
has been shown to accelerate cell migration in response
The results of several studies have provided evidence to cell injury in a renal epithelial cell wound-healing
that renal tubular obstruction plays an important role in model [34]. However, whether the motogenic effect in
the sustained decrease in the glomerular filtration rate this model was due to NO or a metabolite of NO was
(GFR) in acute ischemic renal injury [1–9]. It has been not examined. In a model of cell injury in which oxygen
radicals may be generated, such as wound healing or
ischemia, it is reasonable to consider the role of NOKey words: acute renal failure, collagen, uric acid, superoxide dismu-
tase, LLC-PK1 cells. metabolites, especially peroxynitrite (ONOO2). In this
regard, increased 3-nitrotyrosine, a footprint of ONOO2,Received for publication August 17, 1998
has been shown by Western blot analysis in the outerand in revised form November 20, 1998
Accepted for publication January 5, 1999 stripe of the medulla in ischemic mouse kidney [27], thus
supporting the potential role of ONOO2 in ischemia- 1999 by the International Society of Nephrology
2281
Wangsiripaisan: NO and renal epithelial cell adhesion2282
induced renal injury. Prior to this study, there have been PBS. Cells were counted and resuspended to 50,000 cell
per ml in 0.1% bovine serum albumin in DMEM/F12no studies examining the effect of ONOO2 on renal
tubular epithelial cell adhesion. Therefore, the purpose medium at 378C, pH 7.4. Cells were pretreated with NO
donors and/or scavengers for 30 minutes at 378C. Twoof our study was to compare the effects of NO and
ONOO2 on renal tubular epithelial cell adhesion to sev- hundred microliters of cell suspension were then added
to each well, and the cells were allowed to adhere foreral matrix proteins, including collagen types I and IV
and fibronectin. 90 minutes at 378C. At the end of the 90 minutes, the
supernatant, which contained nonadherent cells, was
gently aspirated, and the cells were washed twice with
METHODS
calcium-free PBS. The number of adherent cells was
Cells and cell culture determined by hexosaminidase enzyme assay as pre-
viously described [35].Three types of renal tubular epithelial cell lines—
porcine proximal tubular cells (LLC-PK1), green monkey
Effect of nitric oxide donors and/or scavengers onkidney (BSC-1) cells, and opossum kidney (OK) cells—
cell adhesionwere purchased from American Type Culture Collection
(ATCC, Rockville, MD, USA). The cells were cultured Nitric oxide was generated by (z)-1-[2-(2-aminoethyl)-
N-(2-ammonioethyl)amino]diazen-1-ium-1,2-diolatein 100 mm diameter cell culture dishes in (1:1) Dulbec-
co’s modified Eagle medium plus Ham’s F12 (DMEM/ (DETA/NO; 500 mm) or spermine NO (SpNO; 500 mm).
NO and superoxide, which immediately interact to formF12), supplemented with 10% fetal bovine serum (con-
taining 2 mm glutamine, 15 mm HEPES, 1.5 g NaHCO3, ONOO2, were simultaneously generated by 3-morpho-
linosydnonimine (SIN-1) at doses of 100, 300, and 500100 unit/ml penicillin G sodium, 100 mg/ml streptomycin
sulfate, pH 7.4), and incubated in 95% air/5% CO2 with mm. The NO scavenger 2-(4-carboxyphenyl)-4,4,5,5-tet-
ramethylimidazoline-1-oxyl-3-oxide (C-PTIO; 100 mm),90% humidity at 378C. Cells were grown to confluence
and were allowed to become quiescent in serum-free the superoxide scavenger superoxide dismutase (SOD;
200 unit/ml), and the ONOO2 scavenger uric acid (UA,medium for 24 hours before the experiments.
100 mm) were added simultaneously with SIN-1 (500 mm)
Coating cell culture plates with matrix proteins during 30 minutes of pretreatment and 90 minutes of cell
adhesion. All NO donors and scavengers were freshlyCollagen type I in 0.02 m acetic acid solution from rat
tail tendon (Upstate Biotechnology, Lake Placid, NY, prepared and dissolved in oxygen-free distilled water
before pretreatment.USA), collagen type IV from basement membrane of
Engelbreth-Holm-Swarm mouse sarcoma (Sigma Chem- Control cells were treated exactly as the treated cells,
but without addition of donors or scavengers. The adhe-ical Co., St. Louis, MO, USA), and human fibronectin
(Sigma Chemical Co.) were coated on 96-well polysty- sion of these untreated control cells was defined as 100%
adhesion. Each experiment (N) represents the mean ad-rene cell culture plates overnight at 48C. A stock solution
of collagen type IV was dissolved in 0.25% glacial acetic hesion of three wells and is expressed as a percentage
of control.acid, and both collagen types I and IV were diluted in
calcium-free phosphate-buffered saline (PBS) to a final In our adhesion assay, SIN-1 showed no direct inhibi-
tory effect on hexosaminidase activity. This was testedconcentration of 20 mg/ml. Fibronectin was dissolved in
calcium-free PBS and was used at a final concentration by incubating LLC-PK1 cells with 500 mm SIN-1 for two
hours and then measuring hexosaminidase activity of theof 5 mg/ml. Fifty microliters of each were then coated
to each well. Before the experiments were performed, total cell lysate. There was no difference in hexosamini-
dase activity (OD405 per 1000 cells 5 control, 0.045 6the protein solution was aspirated, and wells were
washed twice with calcium-free PBS. Nonspecific adhe- 0.002 vs. SIN-1, 0.048 6 0.001; P 5 NS, N 5 6). In
addition, the adhesion data determined by hexosamini-sion was blocked with 2% bovine serum albumin in cal-
cium-free PBS at room temperature for two hours. Prior dase activity were confirmed by cell counting. SIN-1 pre-
treatment reduced cell adhesion to 46.1 6 4.1% by cellto cell adhesion, the blocking solution was removed, and
the wells were washed twice with calcium-free PBS. counting versus 43.4 6 11.3% using the hexosaminidase
method (P 5 NS, N 5 3).
Cell adhesion
Effect of SIN-1 on the integrity of matrix proteinsThe cell monolayer was trypsinized with 0.1% trypsin/
0.04% ethylenediamine tetraacetate (EDTA) in Hank’s Collagen type IV was coated on the plates as described
earlier in this article. After washing of the well, SIN-1balanced salt solution and was allowed to recover for
one hour in DMEM/F12 medium containing 10% fetal (500 mm), which was dissolved in 0.1% bovine serum
albumin in DMEM/F12 medium, was added to thebovine serum. After recovery, the medium was removed,
and the cells were washed three times with calcium-free coated wells and incubated for 90 minutes. The wells
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were then washed twice with calcium-free PBS, and
LLC-PK1 cells were added to the wells. Cell adhesion
was assessed as described earlier here.
Cell viability
Cell viability was determined by the trypan blue dye
exclusion method. Cell adhesion in controls and after
SIN-1 (500 mm) pretreatment was performed as usual;
nonadherent cells were collected by aspiration and cen-
trifugation and were then washed twice with calcium-
free PBS. Adherent cells were trypsinized and collected,
and then trypsin/EDTA was inactivated as described
earlier in this article, using the cell adhesion method.
Both nonadherent and adherent cells were stained with
0.4% trypan blue and counted. Cell viability was ex- Fig. 1. Effect of nitric oxide (NO) donors on LLC-PK1, BSC-1, and
OK cell adhesion to collagen type IV (N 5 7, in each cell type). Cellspressed as a percentage of the absolute viable cells.
were pretreated with each NO donor for 30 minutes, plated in 96-well
culture dishes, and allowed to adhere for 90 minutes. Adherent cellsStatistical analysis were measured by hexosaminidase enzyme assay. Cell adhesion was
expressed as a percentage of control adhesion in each group. SymbolsTo compare values of control and experimental groups
are: (h) DETA/NO 500 mm; ( ) SpNO 500 mm, and (j) SIN-1 500analysis of variance (ANOVA) was used, followed by Dun- mm. **P , 0.01; ***P , 0.001 compared with control in each group.
nett’s test (Instat2 software, version 2.04, GraphPad, San
Diego, CA, USA). A P of less than 0.05 was considered
statistically significant. Data are presented as means 6 sem.
RESULTS
Control LLC-PK1, BSC-1, and OK cell adhesion to
collagen types I and IV and fibronectin
According to our preliminary results (data not shown),
cell adhesion determined at 90 minutes is when the pla-
teau phase of cell adhesion begins. Control cell adhesion
of LLC-PK1, BSC-1, and OK cells to collagen type IV
was 37.3 6 1.6%, 51.5 6 3.2% and 48.4 6 2.4% of total
cells plated, respectively. Control LLC-PK1 cell adhesion
to collagen type I and fibronectin was 48.8 6 2.8% and
40.3 6 1.2%, respectively.
Effect of nitric oxide donors on LLC-PK1, BSC-1, and
OK cell adhesion to collagen type IV
Fig. 2. Effect of nitric oxide (NO) donors on LLC-PK1 cell adhesionAs shown in Figure 1, DETA/NO (500 mm) did not
to collagen type I (N 5 4) and fibronectin (N 5 6) in comparison toattenuate cell adhesion in any cell line (LLC-PK1, 96.4 6 collagen type IV (N 5 7). Cell adhesion was measured as described in
3.1%; BSC-1, 96.3 6 1.8%; OK, 95.4 6 1.9% vs. control, Figure 1. Cell adhesion was expressed as a percentage of control adhe-
sion in each group. Symbols are: (h) DETA/NO 500 mm; ( ) SpNOP 5 NS, N 5 7 in each cell type). SpNO (500 mm) slightly
500 mm; (j) SIN-1 500 mm. **P , 0.01; ***P , 0.001 compared withattenuated cell adhesion in LLC-PK1 cell (83.6 6 2.4% control in each group.
vs. control, P , 0.01, N 5 7), but did not attenuate cell
adhesion in BSC-1 cells (94.3 6 1.5% vs. control, P 5
NS, N 5 7) or OK cells (89.5 6 1.9% vs. control, P 5
Effect of nitric oxide donors on LLC-PK1 cellNS, N 5 7). In contrast, SIN-1 (500 mm) dramatically
adhesion to collagen type I and fibronectin asattenuated cell adhesion in all cell lines (LLC-PK1, 45.9 6
compared with collagen type IV4.2%; BSC-1, 63.6 6 1.6%; OK, 78.3 6 3.7% vs. control;
P , 0.001, N 5 7 in each cell type). The results with SIN-1 Cell adhesion experiments were also conducted with
collagen type I and fibronectin in order to examine thewere confirmed by cell counting. SIN-1 pretreatment
reduced cell adhesion to 46.1 6 4.1% by cell counting effect of SIN-1 on cell adhesion to different matrix pro-
teins (Fig. 2). DETA/NO (500 mm) had no effect on cellversus 43.4 6 11.3% using the hexosaminidase method
(P 5 NS, N 5 3). adhesion to any of the three matrices (collagen type I,
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98.0 6 2.5% vs. control, P 5 NS, N 5 4; fibronectin, scavenger SOD (200 unit/ml), and the ONOO2 scaven-
ger uric acid (100 mm) reversed the effect of SIN-1 on95.7 6 4.2% vs. control, P 5 NS, N 5 6; collagen type
IV, 96.4 6 3.1% vs. control, P 5 NS, N 5 7). SpNO cell adhesion in all cell lines and matrix proteins (Fig.
6). With cell adhesion to collagen type IV (N 5 7),(500 mm) also had no effect on cell adhesion to collagen
type I (98.4 6 5.4% vs. control, P 5 NS, N 5 4), but C-PTIO reversed the effect of SIN-1 on LLC-PK1 (87.8 6
1.6% vs. control, P , 0.05), BSC-1 (92.8 6 2.0% vs.had a modest effect on cell adhesion to fibronectin
(82.3 6 2.2% vs. control, P , 0.01, N 5 6) similar to control, P 5 NS), and OK cell adhesion (89.2 6 2.1%
vs. control, P 5 NS). SOD reversed the effect of SIN-1collagen type IV. SIN-1 (500 mm) dramatically attenu-
ated LLC-PK1 cell adhesion to collagen-type I (47.0 6 on LLC-PK1 (95.8 6 5.2% vs. control, P 5 NS), BSC-1
(99.0 6 1.7% vs. control, P 5 NS), and OK cell adhesion6.0% vs. control, P , 0.001, N 5 4) and fibronectin
(41.6 6 3.8% vs. control, P , 0.001, N 5 6) in a manner (93.5 6 8.0% vs. control, P 5 NS). Uric acid reversed
the effect of SIN-1 on LLC-PK1 (96.7 6 3.1% vs. control,similar to that observed with collagen type IV.
P 5 NS), BSC-1 (101.2 6 3.4% vs. control, P 5 NS),
Dose-dependent effect of SIN-1 on LLC-PK1, BSC-1, and OK cell adhesion (98.5 6 2.4% vs. control, P 5 NS).
and OK cell adhesion to collagen types I and IV The effect of SIN-1 on LLC-PK1 cell adhesion to colla-
and fibronectin gen type I (N 5 4) was also reversed by C-PTIO (98.4 6
2.4% vs. control, P 5 NS), SOD (103.4 6 11.9% vs.The effect of SIN-1 on cell adhesion to collagen type
IV was dose dependent in all cell lines (Fig. 3A). It was control, P 5 NS), and uric acid (93.3 6 3.1 vs. control,
P 5 NS).most prominent in the LLC-PK1 cell (100 mm, 82.7 6
2.5%; 300 mm, 53.3 6 4.7%; 500 mm, 45.9 6 4.2%, N 5 The scavengers demonstrated a similar pattern on
SIN-1–treated LLC-PK1 cell adhesion to fibronectin:7). A less prominent effect was seen in the BSC-1 cell
(100 mm, 93.1 6 3.7%; 300 mm, 79.0 6 3.2%; 500 mm, C-PTIO (90.6 6 2.6% vs. control, P 5 NS, N 5 6), SOD
63.6 6 1.6%, N 5 7), and a modest effect was observed (89.3 6 3.5% vs. control, P 5 NS, N 5 6), and uric acid
in the OK cell (100 mm, 93.0 6 2.7%; 300 mm, 92.6 6 (96.2 6 2.5% vs. control, P 5 NS, N 5 6).
4.0%; 500 mm, 78.3 6 3.7%, N 5 7). The effect of SIN-1
Dose-dependent effects of nitric oxide, superoxide,on LLC-PK1 cell adhesion to collagen type I (100 mm,
and ONOO2 scavengers on SIN-1 effect to decrease94.1 6 2.2%; 300 mm, 62.5 6 5.1%; 500 mm, 47.0 6 6.0%,
LLC-PK1 cell adhesion to collagen type IVN 5 4) and fibronectin (100 mm, 84.9 6 1.6%; 300 mm,
52.9 6 4.5%; 500 mm, 41.6 6 3.8%, N 5 6) was also dose Each scavenger reversed the effect of SIN-1 (500 mm)
dependent (Fig. 3B), as occurred with collagen type IV. on LLC-PK1 cell adhesion to collagen type IV in a dose-
dependent manner. C-PTIO (100 mm; Fig. 7A) and uric
Effect of SIN-1 on viability of adherent and acid (100 mm; Fig. 7C) completely reversed the effect
nonadherent LLC-PK1 cells of SIN-1. SOD at concentrations of 100 to 200 unit/ml
Cell viability was determined by trypan blue dye exclu- reversed the effect of SIN-1 to approximately 80% of
sion after a 120-minute exposure to SIN-1 (500 mm). the control (Fig. 7B).
There was no difference in viability between control and
SIN-1–pretreated cells, either in adherent (SIN-1, 95.3 6
DISCUSSION1.7% vs. control, 93.8 6 2.2%, P 5 NS, N 5 4) or
Nitric oxide is a very important molecule in biologicalnonadherent cells (SIN-1, 79.8 6 2.3% vs. control, 78.0 6
systems, and its diversified effects have been extensively4.0%, P 5 NS, N 5 4) plated on collagen type IV (Fig. 4).
studied. Nevertheless, there are some controversial data
Effect of SIN-1 on coated collagen type IV about its beneficial and injurious effects. NO is a reactive
radical that has a relatively short biological half-life [36]After SIN-1 (500 mm) was incubated in wells coated
and reacts with many biological molecules such as oxy-with collagen type IV (20 mg/ml, 50 ml/well), there was
gen and its radicals, transition metals, thiol groups, andno difference in subsequent LLC-PK1 cell adhesion to
antioxidants. In addition, NO influences a number ofthe SIN-1–exposed collagen type IV (98.0 6 4.7%) ver-
signal transduction pathways and biosynthetic systemssus unexposed collagen type IV (100%, P 5 NS, N 5
that are essential for normal cellular function [37]. NO4; Fig. 5).
can be rapidly inactivated by oxyhemoglobin [38, 39].
Nitric oxide, superoxide, and ONOO2 scavengers Not only the diversified effects of NO, but also different
reversed the effect of SIN-1 on LLC-PK1, BSC-1, NO synthase (NOS) isoforms, by which NO is produced
and OK cell adhesion to collagen types I and IV in vivo, contribute to the ultimate effects of the molecule.
and fibronectin The endothelial NOS and neuronal NOS, which generate
NO at more physiological concentrations, seem to haveSimultaneous incubation of SIN-1 (500 mm) with either
the NO scavenger C-PTIO (100 mm), the superoxide mainly beneficial or protective effects. In contrast, induc-
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Fig. 3. Dose-dependent effect of SIN-1 on
cell adhesion. (A) LLC-PK1 (r), BSC-1 (j),
and OK (d) cell adhesion to collagen type IV
(N 5 7, in each cell type). (B) LLC-PK1 cell
adhesion on collagen type IV (r; N 5 7),
collagen type I (d; N 5 4), and fibronectin
(j; N 5 6). Cell adhesion was measured as
described in Figure 1. Cell adhesion was ex-
pressed as a percentage of control adhesion
in each group. **P , 0.01; ***P , 0.001 com-
pared with control in each group.
Fig. 4. Effect of SIN-1 (500 mM; j) on cell viability of adherent (N 5
Fig. 5. Effect of SIN-1 on coated collagen type IV. Collagen type IV-4) and nonadherent LLC-PK1 cells (N 5 4) compared with control (h).
coated culture wells were exposed to SIN-1 for 90 minutes and washed,Experiments were performed on collagen type IV-coated 96-well cell
and LLC-PK1 cell adhesion was measured as described in Figure 2. Cellculture plates as described in Figure 1, and cell viability was determined
adhesion was expressed as the percentage of control adhesion. Symbolsby trypan blue dye exclusion.
are: (j) non–SIN-1 exposed (N 5 4); (h) SIN-1 (500 mm)–exposed
coated collagen type IV (N 5 4).
ible NOS, which generates greater amounts of NO during
inflammation and injury, tends to have injurious effects. [28]. Thus, it is conceivable that the effects of NO and/
or its metabolite in biological systems depend largely onHowever, recent results revealed opposite effects of vas-
cular smooth muscle NOS and macrophage NOS, both the location and nature of the NOS isoform, surrounding
reactive molecules, balance between NO generation andof which are inducible NOS isoforms, in postischemic
ARF in rats [28]. In these studies, when rats were treated degradation, and other opposing mechanisms. Although
NO may have a protective role on renal hemodynamics,with antisense oligodeoxynucleotides specific for the
macrophage NOS isoform, renal function was dramati- in renal tubules, the effects of NO are less clear. Al-
though an NO donor has been shown to have a moto-cally protected from ischemia/reperfusion injury. In con-
trast, animals treated with antisense oligodeoxynucleo- genic effect on renal epithelial cells in culture [34, 40],
whether this effect on cell adhesion is due to NO itselftides specific for vascular smooth muscle NOS showed
markedly greater renal impairment than the untreated or its metabolite, ONOO2 has not been examined.
In this study, the role of NO and ONOO2 on renalanimals subjected to the same renal ischemia/reperfusion
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Fig. 6. Scavengers of either NO (C-PTIO),
O22 (SOD), or ONOO2 (UA) reversed the
SIN-1 (500 mM) effect on LLC-PK1, BSC-1,
and OK cell adhesion to collagen type IV (N 5
7), collagen type I (N 5 4), and fibronectin
(N 5 6). Scavengers were added simultane-
ously with the SIN-1, and cell adhesion was
measured as described in Figure 2. Cell adhe-
sion was expressed as a percentage of control
adhesion in each group. Symbols are: (j)
SIN-1; ( ) SIN-1 1 C-PTIO (100 mm); ( )
SIN-1 1 SOD (200 unit/ml); (h) SIN-1 plus
uric acid (100 mm). *P , 0.05; ***P , 0.001
compared with control in each group.
Fig. 7. Dose-dependent effect of scavengers
on SIN-1–treated LLC-PK1 cell adhesion to
collagen type IV. (A) NO scavenger, C-PTIO,
N 5 4. (B) superoxide scavenger, SOD,
N 5 4. (C) ONOO2 scavenger, UA, N 5 4.
Scavengers were added simultaneously with
the SIN-1, and cell adhesion was measured
as described in Figure 2. Cell adhesion was
expressed as a percentage of control adhesion
in each group. ***P , 0.001 compared with
control in each group.
tubular epithelial cell adhesion was examined. Only Moreover, SIN-1 attenuated LLC-PK1, BSC-1, and
OK cell adhesion in a dose-dependent manner. The ef-SIN-1, which generates both NO and superoxide, which
rapidly react to form ONOO2 [41], significantly and con- fect of SIN-1 on renal tubular cell adhesion was also
demonstrated on different matrix proteins, that is, base-sistently decreased renal tubular epithelial cell adhesion
in LLC-PK1, BSC-1, and OK cell lines. In contrast, NO ment membrane (collagen type IV and fibronectin) and
interstitium (collagen type I). In this regard, differentgenerated from DETA/NO and SpNO had virtually no
effect on cell adhesion. stress situations may alter matrix proteins, and such alter-
ations may affect cell-matrix adhesion [45]. However, inThe amount of ONOO2 generated from 500 mm SIN-1
at 378C, pH 7.4, was estimated to be approximately 5 mm/ this study, 500 mm of SIN-1 was shown to have no effect
on matrix protein integrity. Furthermore, cell viabilitymin [41, 42]. In this regard, it has been reported that
NO can increase to 1 to 5 mm during acute inflammation, with SIN-1 was not different from controls.
To confirm the effect of ONOO2 in our study, scaven-ischemia/reperfusion, or sepsis [43]. Because the rate
of ONOO2 formation depends on the product of the gers of NO, superoxide, and ONOO2 were individually
added simultaneously with the SIN-1. C-PTIO was usedsuperoxide and NO concentrations [44], it may there-
fore be possible for low micromolar concentrations of to scavenge NO, SOD to scavenge superoxide, and uric
acid to scavenge ONOO2 [46, 47]; all three separatelyONOO2 (similar to those used in our study) to be gener-
ated in vivo. reversed the effect of SIN-1 on cell adhesion in a dose-
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medium plus Ham’s F12; EDTA, ethylenediamine tetraacetate; GFR,dependent manner. Because the NO donors DETA/NO
glomerular filtration rate; NO, nitric oxide; NOS, nitric oxide synthase;
and SpNO demonstrated little or no effect on renal tubu- PBS, phosphate-buffered saline; ONOO2, peroxynitrite; SIN-1, 3-mor-
pholinosydnonimine; SOD, superoxide dismutase; SpNO, sperminelar cell-matrix adhesion, the inhibition by C-PTIO and
NO; UA, uric acid.SOD of the SIN-1–mediated decrease in cell adhesion
suggested that ONOO2 and not NO itself was account-
REFERENCESable for the effect.
This interpretation was supported by the effect of the 1. Solez K, Morel-Maroger L, Sraer J-D: The morphology of
“acute tubular necrosis” in man: Analysis of 57 renal biopsiesONOO2scavenger, uric acid, to block the effect of SIN-1.
and a comparison with the glycerol model. Medicine (Baltimore)
During cell-matrix adhesion, adhesion molecules on 58:362–376, 1979
2. Myers BD, Miller DC, Mehigan JT, Olcott C, Golbetz H,cell membrane surfaces recognize their matrix protein
Robertson CR, Derby G, Spencer R, Friedman S: Nature of thereceptors as an initial step of adhesion. After focal adhe-
renal injury following total renal ischemia in man. J Clin Invest
sion clustering, a cascade of events occurs, including actin 73:329–341, 1984
3. Moran SM, Myers BD: Pathophysiology of protracted acute renalmicrofilament/actin-binding protein assembly, cell–cell
failure in man. J Clin Invest 76:1440–1448, 1985adhesion, cell membrane polarity establishment, and a
4. Myers BD, Morn SM: Hemodynamically mediated acute renal
variety of signal transductions. Once focal adhesion is failure. N Engl J Med 314:97–105, 1986
5. Tanner GA, Sophasan S: Kidney pressure after temporary renalinitially established, more stable cell-matrix adhesion ne-
artery occlusion in the rat. Am J Physiol 230:1173–1181, 1976cessitates further events. If any of these steps are dis-
6. Arendshorst WJ, Finn WF, Gottschalk CW, Lucas HK: Micro-
turbed, fully developed cell-matrix adhesion will not oc- puncture study of acute renal failure following temporary renal
ischemia in the rat. Kidney Int 10(Suppl 6):S100–S105, 1976cur. Although ONOO2 is relatively nonreactive, its
7. Fry IK, Cattell WR: The nephrographic pattern during excretionconjugate acid, peroxynitrous acid (HO-O-N 5 O), is
urography. Br Med Bull 28:227–232, 1972
an inorganic peroxyacid and is more reactive [48]. Pre- 8. Cattell WR, McIntosh CS, Mosely IF, Fry IK: Excretion urogra-
phy in acute renal failure. BMJ 2:575–578, 1973sumably, at least 20% of ONOO2 at pH 7.4, 378C, in
9. Sherwood T, Evans DJ: Intravenous urography in experimentalour experiment was already protonated to form peroxy-
acute renal failure. Nephron 22:577–581, 1978
nitrous acid [48], because the pKa of ONOO2 is 6.8 at 10. Patel R, McKenzie JK, McQueen EG: Tamm-Horsfall urinary
mucoprotein and tubular obstruction by casts in acute renal failure.378C [49]. ONOO2 is capable of oxidizing a variety of
Lancet 1:457–461, 1964biological molecules, including sulfides [50], thiols [51],
11. Racusen LC, Fivush BA, Li Y-L: Dissociation of tubular cell
deoxyribose [44], lipids [52], a-1 proteinase inhibitor detachment and tubular cell death in clinical and experimental
“acute tubular necrosis.” Lab Invest 64:546–556, 1991[53], and ascorbate [54]. ONOO2 also may cause nitrate
12. Graber M, Lane B, Lamina R, Pastroiza-Munoz E: Bubble cells:tyrosine residues [55, 56] and may possibly cause protein
Renal tubular cells in the urinary sediment with characteristics of
fragmentation. Therefore, ONOO2 is possibly capable viability. Am J Soc Nephrol 1:999–1004, 1991
13. Molitoris BA, Nelson WJ: Alterations in the establishment andof altering protein function [57, 58] and may affect renal
maintenance of epithelial cell polarity as a basis for disease pro-tubular cell-matrix adhesion. However, the mechanism
cesses. J Clin Invest 85:3–9, 1990
by which ONOO2 attenuates renal tubular cell-matrix 14. Molitoris BA: Ischemia-induced loss of epithelial polarity: Poten-
tial role of the actin cytoskeleton. Am J Physiol 260:F769–F778,adhesion needs further study.
1991In conclusion, these results provide evidence that
15. Kroshian VM, Sheridan AM, Lieberthal W: Functional and
ONOO2, not NO itself or superoxide, attenuates renal cytoskeleton changes induced by sublethal injury in proximal tubu-
lar epithelial cells. Am J Physiol 266:F21–F30, 1994tubular cell-matrix adhesion in a dose-dependent man-
16. Carter WG, Wayner EA, Bouchard TS, Kaur P: The role ofner. If ONOO2 is produced during ischemia/reperfusion integrins a21 and a31 in cell-cell and cell-substrate adhesion of hu-
in ARF, it therefore may affect renal tubular cell-base- man epidermal cells. J Cell Biol 110:1387–1404, 1990
17. Meredith JE Jr, Fazeli B, Schwartz MA: The extracellular ma-ment membrane adhesion and may contribute to tubular
trix as a cell survival factor. Mol Biol Cell 4:953–961, 1993obstruction. 18. Frisch SM, Francis H: Disruption of epithelial cell-matrix interac-
tions induces apoptosis. J Cell Biol 124:619–626, 1994
19. Ruoslahti E, Reed JC: Anchorage dependence, integrins, andACKNOWLEDGMENTS
apoptosis. Cell 77:477–478, 1994
This research was supported by grants from the National Institutes 20. Wilson PD, Schrier RW: Nephron segment and calcium as deter-
of Health (DK35098 and DK52599). minants of anoxic cell death in primary renal cell cultures. Kidney
Int 29:1172–1179, 1996
Reprint requests to Robert W. Schrier, M.D., University of Colorado 21. Schwertschlag U, Schrier RW, Wilson P: Beneficial effects of
Health Sciences Center, Box B178, 4200 East 9th Avenue, Denver, calcium channel blockers and calmodulin binding drugs on in vitro
Colorado 80262, USA. renal cell anoxia. J Pharmacol Exp Ther 238:119–124, 1986
E-mail: Robert.Schrier@UCHSC.edu 22. Almeida AR, Bunnachak D, Burnier M, Wetzels JFM, Burke
TJ, Schrier RW: Time-dependent protective effects of calcium
channel blockers on anoxia and hypoxia-induced proximal tubule
injury. J Pharmacol Exp Ther 260:526–532, 1992APPENDIX
23. Wetzels JFM, Yu L, Wang X, Kribben A, Burke TJ, Schrier
Abbreviations used in this article are: ARF, acute renal failure; RW: Calcium modulation and cell injury in isolated rat proximal
C-PTIO, 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl- tubules. J Pharmacol Exp Ther 273:206–212, 1993
3-oxide; DETA/NO, (z)-1-[2-(2-aminoethyl)-N-(2-ammonioethyl)ami- 24. Kribben A, Wieder ED, Wetzels JFM, Yu L, Gengaro PE,
Burke TJ, Schrier RW: Evidence for role of cytosolic free calciumno]diazen-1-ium-1,2-diolate; DMEM/F12, Dulbecco’s modified Eagle
Wangsiripaisan: NO and renal epithelial cell adhesion2288
in hypoxia-induced proximal tubule injury. J Clin Invest 93:1922– 42. Crow JP, Ischiropoulos H: Detection and quantitation of nitroty-
rosine residues in proteins: In vivo marker of peroxynitrite, in1929, 1994
25. Yu L, Gengaro PE, Niederberger M, Burke TJ, Schrier RW: Methods in Enzymology: Nitric oxide (vol 269, part B) Physiologi-
cal and Pathological Processes, edited by Packer L, San Diego,Nitric oxide: A mediator in rat tubular hypoxia/reoxygenation in-
jury. Proc Natl Acad Sci USA 91:1691–1695, 1994 Academic Press, 1996, pp 185–194
43. Liu P, Hock CE, Nagele R, Wong PYK: Formation of nitric oxide,26. Yaqoob MM, Edelstein CL, Wieder ED, Alkhunaizi A, Gen-
garo PE, Schrier RW: Nitric oxide kinetics during hypoxia in superoxide, and peroxynitrite in myocardial ischemia-reperfusion
injury in rats. Am J Physiol 272:H2327–H2336, 1997proximal tubules: Effects of acidosis and glycine. Kidney Int
49:1314–1319, 1996 44. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA:
Apparent hydroxyl radical production by peroxynitrite: Implica-27. Chiao H, Kohda Y, McLeroy P, Craig L, Housini I, Star RA:
tions for endothelial injury from nitric oxide and superoxide. Proca-Melanocyte stimulating hormone protects against renal injury
Natl Acad Sci USA 87:1620–1624, 1990after ischemia in mice and rats. J Clin Invest 99:1165–1172, 1997
45. Vissers MCM, Winterbourn CC: Oxidative damage to fibronec-28. Noiri E, Peresleni T, Miller F, Goligorsky MS: In vivo targeting
tin. Arch Biochem Biophys 285:357–364, 1991of inducible NO synthase with oligodeoxynucleotides protects rat
46. Whiteman M, Halliwell B: Protection against peroxynitrite-kidney against ischemia. J Clin Invest 97:2377–2383, 1996
dependent tyrosine nitration and alpha-1-antiproteinase inactiva-29. Kubes P, Suzuki M, Granger DN: Nitric oxide: An endogenous
tion by ascorbic acid: A comparison with other biological antioxi-modulator of leukocyte adhesion. Proc Natl Acad Sci USA 88:4651–
dants. Free Radic Res 25:275–283, 19964655, 1991
47. Hooper DC, Spitsin S, Kean RB, Champion JM, Dickson GM,30. Niu X-F, Smith CW, Kubes P: Intracellular oxidative stress induced
Chaudhry I, Koprowski H: Uric acid, a natural scavenger ofby nitric oxide synthesis inhibition increases endothelial cell adhe-
peroxynitrite, in experimental allergic encephalomyelitis and mul-sion to neutrophils. Circ Res 74:1133–1140, 1994
tiple sclerosis. Proc Natl Acad Sci USA 95:675–680, 199731. Gauthier TW, Davenpeck KL, Lefer AM: Nitric oxide attenuates
48. Pryor WA, Squadrito GL: The chemistry of peroxynitrite: Aleukocyte-endothelial interaction via P-selectin in splanchnic ische-
product from the reaction of nitric oxide with superoxide. Am Jmia-reperfusion. Am J Physiol 267:G562–G568, 1994
Physiol 268:L699–L722, 199532. Adams MR, McCredie R, Jessup W, Robinson J, Sullivan D,
49. Koppenol WH, Moreno JJ, Pryor WA, Ischiropoulos H, Beck-Celermajer DS: Oral L-arginine improves endothelium-depen-
man JS: Peroxynitrite: A cloaked oxidant from superoxide anddent dilatation and reduces monocyte adhesion to endothelial cells
nitric oxide. Chem Res Toxicol 5:834–842, 1992in young men with coronary artery disease. Atherosclerosis 129:
50. Pryor WA, Jin X, Squadrito GL: One- and two-electron oxida-261–269, 1997
tions of methionine by peroxynitrite. Proc Natl Acad Sci USA33. Yao J, Schoecklmann HO, Prols F, Gauer S, Sterzel RB: Exoge-
91:11173–11177, 1994nous nitric oxide inhibits mesangial cell adhesion to extracellular 51. Radi R, Beckman JS, Bush KM, Freeman BA: Peroxynitrite oxida-matrix components. Kidney Int 53:598–608, 1998 tion of sulfhydryls: The cytotoxic potential of superoxide and nitric34. Noiri E, Peresleni T, Srivastava N, Weber P, Bahou WF, Peu- oxide. J Biol Chem 266:4244–4250, 1991
nova N, Goligorsky MS: Nitric oxide is necessary for a switch 52. Radi R, Beckman JS, Bush KM, Freeman BA: Peroxynitrite-
from stationary to locomoting phenotype in epithelial cells. Am J induced membrane lipid peroxidation: The cytotoxic potential of
Physiol 270:C794–C802, 1996 superoxide and nitric oxide. Arch Biochem Biophys 288:481–487,
35. Landegren U: Measurement of cell numbers by means of the 1991
endogenous enzyme hexosaminidase: Application to detection of 53. Moreno JJ, Pryor WA: Inactivation of a-1-proteinase inhibitor
lymphokines and cell surface antigens. J Immunol Methods 67:379– by peroxynitrite. Chem Res Toxicol 5:425–431, 1992
388, 1984 54. Bartlett D, Church DF, Bounds PL, Koppenol WH: The kinetics
36. Kelm M, Schrader J: Nitric oxide release from the isolated guinea of the oxidation of L-ascorbic acid by peroxynitrite. Free Radic
pig heart. Eur J Pharmacol 155:317–321, 1988 Biol Med 18:85–92, 1995
37. Kone BC: Nitric oxide in renal health and disease. Am J Kidney 55. Ischiropoulos H, Zhu L, Chen J, Tsai M, Martin JC, Smith CD,
Dis 30:311–333, 1997 Beckman JS: Peroxynitrite-mediated tyrosine nitration catalyzed
38. Doyle MP, Hoekstra JW: Oxidation of nitrogen oxides by bound by superoxide dismutase. Arch Biochem Biophys 298:431–437,
dioxygen in hemoproteins. J Inorg Chem 14:351–358, 1981 1992
39. Goretski J, Hollocher TC: Trapping of nitric oxide produced 56. Van Der Vliet A, O’Neill CA, Halliwell B, Cross CE, Kaur
during denitrification by extracellular hemoglobin. J Biol Chem H: Aromatic hydroxylation and nitration of phenylalanine and
263:2316–2323, 1988 tyrosine by peroxynitrite: Evidence for hydroxyl radical production
40. Goligorsky MS, Noiri E, Peresleni T, Hu Y: Role of nitric oxide from peroxynitrite. FEBS Lett 339:89–92, 1994
in cell adhesion and locomotion. Exp Nephrol 4:314–321, 1996 57. Chantler PD, Gratzer WB: Effects of specific chemical modifica-
41. Kelm M, Dahmann R, Wink D, Feelisch M: The nitric oxide/ tion of actin. Eur J Biochem 60:67–72, 1975
superoxide assay: Insights into the biological chemistry of the 58. Ischiropoulos H, Al-Mehdi AB: Peroxynitrite-mediated oxida-
tive protein modifications. FEBS Lett 364:279–282, 1995NO/superoxide interaction. J Biol Chem 272:9922–9932, 1997
